Head of Da Nang Hi-Tech Park and Industrial Zones Authorities, Pham Truong Son (right) gives a licence, approving a stem cell research project, to a representative of the Asia Hi-Tech Joint Stock Company. (Photo: VNA)
|
The 20 million USD project, developed by the Asia Hi-Tech Joint Stock Company, will cover scientific research in stem cells including bone marrow cells, umbilical cords, and skin cells for transplant cases, cancer treatment and cosmetic surgeries.
It’s expected to be put into operation in the second quarter of 2024, supplying 300,000 stem cell samples per year.